More importantly, the administration of Fevipiprant prior to the injection of [18F]MK-7246 could decrease the uptake signal in the mouse with a tumor developed from GPR44-expressing CHO-K1 cells (SUV = 0.59) (Figure 9A). Here, PTGDR2 is linked to neoplasm.